Guardian Pharmacy Services Inc. (GRDN)
GRDN trades on NYSE in Consumer Staples, Retail-Drug Stores and Proprietary Stores. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1802255/000119312526102172/0001193125-26-102172-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | GRDN on NYSE |
| Sector | Consumer Staples |
| Industry | Retail-Drug Stores and Proprietary Stores |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001802255 |
| SEC industry code | Retail-Drug Stores and Proprietary Stores |
| Incorporated in | GA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.4B |
| Net income | $49.2M |
| Operating income | $72.7M |
| Net margin | 3.4% |
| Operating margin | 5.0% |
| Revenue growth | +17.9% |
| Cash | $65.6M |
| Total assets | $412.7M |
| P/E (computed) | 63.6× |
| P/S (computed) | 2.2× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $119.7M cash; operating cash flow $28.5M a quarter. | Report 2026-09-30 |
| Shares outstanding | 63,353,919 (2026-11-03); 63,320,634 a year earlier. | Cover page 2026-11-03 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-03-20 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Ernst & Young LLP, Atlanta, Georgia, United States | PCAOB Form AP 2026-03-25 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $100K, sold $174.5M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $371.1M | $18.7M | $43.4M | $119.7M | No debt tags | $1.5B | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $351.8M | $21.9M | $30.0M | $89.8M | No debt tags | $1.5B | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $336.6M | $13.3M | $6.1M | $64.9M | No debt tags | $1.5B | 10-Q 2026-05-06 |
| Q4 2025 2025-12-31 | $397.6M | $20.9M | $34.6M | $65.6M | $0 | $1.4B | 10-K 2026-03-11 |
| Q3 2025 2025-09-30 | $377.4M | $9.8M | $28.2M | $36.5M | No debt tags | $1.4B | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $344.3M | $9.0M | $19.9M | $18.8M | No debt tags | $1.3B | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $329.3M | $9.4M | $17.6M | $14.0M | No debt tags | $1.3B | 10-Q 2026-05-06 |
| Q4 2024 2024-12-31 | $338.6M | $11.9M | $22.3M | $4.7M | $0 | $1.2B | 10-K 2026-03-11 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-05-06 |
| Latest annual report | 10-K | 2026-03-11 |
| Latest quarterly / interim | 10-Q | 2026-11-05 |
| Latest current report | 8-K | 2026-11-05 |
| Latest proxy | DEFA14A | 2026-03-26 |
Source: SEC EDGAR submissions feed, 226 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +16.8% |
| 1 month | +24.4% |
| 3 months | +28.8% |
| Year to date | +64.6% |
| 1 year | +62.8% |
| From 52-week high | -0.9% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Retail-Drug Stores and Proprietary Stores
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CVS | CVS Health Corporation | $88.59 | -0.85% | $113.3B |
| YI | 111 Inc. | $2.84 | -0.35% | $25.0M |
| PETS | PetMed Express Inc. | $0.8977 | -4.52% | $20.0M |
| RDGT | Ridgetech Inc. | $1.01 | -4.72% | $3.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier